KTTA
Pasithea·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 0
Ample Liquidity
Bullish Abandoned Baby
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About KTTA
Pasithea Therapeutics Corp.
A biotech company focused on developing psychedelic-based therapeutics for mental health disorders
1111 Lincoln Road, Suite 500, Miami Beach, FL 33139
--
Pasithea Therapeutics Corp. was incorporated in Delaware on May 12, 2020. The company engages in psychiatric and neurological research on CNS disorders with the goal of translating this research into clinically-usable drugs.
Company Financials
EPS
KTTA has released its 2025 Q2 earnings. EPS was reported at -0.66, versus the expected 0, missing expectations. The chart below visualizes how KTTA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
